About Viome Life Sciences
Viome Life Sciences is a company based in Bothell (United States) founded in 2016 by Momchilo Momo Vuyisich and Naveen Jain. Viome Life Sciences has raised $92.44 million across 2 funding rounds from investors including Khosla Ventures, Glico Group and BOLD Capital Group. Viome Life Sciences offers products and services including Diagnostic Tests, Precision Nutrition, Predictive Biomarkers, and Therapeutics Development. Viome Life Sciences operates in a competitive market with competitors including Prometheus Laboratories, InDex Pharmaceuticals, NinePoint Medical, Proteomics International and Given Imaging, among others.
- Headquarter Bothell, United States
- Founders Momchilo Momo Vuyisich, Naveen Jain
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Viome Life Sciences, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$92.44 M (USD)
in 2 rounds
-
Latest Funding Round
$25.44 M (USD), Series C
Aug 19, 2024
-
Investors
Khosla Ventures
& 5 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Viome Life Sciences
Viome Life Sciences offers a comprehensive portfolio of products and services, including Diagnostic Tests, Precision Nutrition, Predictive Biomarkers, and Therapeutics Development.
Analyzes RNA for predictive health insights and chronic disease detection.
Provides tailored nutrition plans based on microbiome data for wellness.
Identifies disease signatures through microbial analysis for early intervention.
Develops drugs and vaccines targeting microbiome-related conditions.
People of Viome Life Sciences
Unlock access to complete
Unlock access to complete
Funding Insights of Viome Life Sciences
Viome Life Sciences has successfully raised a total of $92.44M across 2 strategic funding rounds. The most recent funding activity was a Series C round of $25.44 million completed in August 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Viome Life Sciences
Viome Life Sciences has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Khosla Ventures, Glico Group and BOLD Capital Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage startups are funded by this venture capital firm.
|
Locked | Locked | Locked | |
|
Investments are focused across multiple sectors by the firm.
|
Locked | Locked | Locked | |
|
Venture capital is invested in companies across multiple sectors.
|
Locked | Locked | Locked |
Investor details for Viome Life Sciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Viome Life Sciences
Investment portfolio details for Viome Life Sciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Viome Life Sciences
Detailed financials for Viome Life Sciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Viome Life Sciences Comparisons
Peer comparison for Viome Life Sciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Viome Life Sciences
Viome Life Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Prometheus Laboratories, InDex Pharmaceuticals, NinePoint Medical, Proteomics International and Given Imaging, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Diagnostics and therapeutics for gastrointestinal and personalized medicine are developed.
|
|
| Locked | Locked | Locked |
DNA-based immunomodulatory drugs for ulcerative colitis are developed.
|
|
| Locked | Locked | Locked |
Optical coherence tomography systems for tissue microstructure imaging are developed.
|
|
| Locked | Locked | Locked |
Medical technology company at the forefront of predictive diagnostics and bio-analytical services
|
|
| Locked | Locked | Locked |
Capsule endoscopy systems for GI imaging
|
Detailed competitors of Viome Life Sciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Viome Life Sciences
Complete news archive for Viome Life Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Viome Life Sciences
Viome Life Sciences was founded in 2016 and raised its 1st funding round 6 years after it was founded.
Viome Life Sciences is headquartered in Bothell, United States. It is registered at Bothell, Washington, United States.
Naveen Jain is the current CEO of Viome Life Sciences. They have also founded this company.
Viome Life Sciences is a funded company, having raised a total of $92.44M across 2 funding rounds to date.
Provider of tests to prevent, treat, and cure chronic diseases, and cancer. It uses AI and proprietary mRNA sequencing technology to develop a CancerDetect test for oral throat cancer. The company platform enables to development of predictive biomarkers, precision diagnostics, and precision therapeutics to prevent and intercept chronic diseases. It has also developed 30 predictive models for Glycemic response, Obesity, Diabetes, Depression, IBS, and Oral Cancer.
Viome Life Sciences's top competitors include Prometheus Laboratories, NinePoint Medical and Proteomics International.
Viome Life Sciences offers Diagnostic Tests, Precision Nutrition, Predictive Biomarkers, and Therapeutics Development.
Viome Life Sciences has 6 investors. Key investors include Khosla Ventures, Glico Group, BOLD Capital Group, WestRiver Group, and Ocgrow Group of Companies.